GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Common Stock

LumiraDx (LumiraDx) Common Stock : $858.43 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Common Stock?

LumiraDx's quarterly common stock increased from Dec. 2022 ($858.09 Mil) to Mar. 2023 ($858.26 Mil) and increased from Mar. 2023 ($858.26 Mil) to Jun. 2023 ($858.43 Mil).

LumiraDx's annual common stock increased from Dec. 2020 ($152.73 Mil) to Dec. 2021 ($754.02 Mil) and increased from Dec. 2021 ($754.02 Mil) to Dec. 2022 ($858.09 Mil).

LumiraDx Common Stock Historical Data

The historical data trend for LumiraDx's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Common Stock Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Common Stock
- 152.73 754.02 858.09

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 758.11 853.51 858.09 858.26 858.43

LumiraDx Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

LumiraDx (LumiraDx) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Common Stock
Comparable Companies
DRIO XGN AKUMQ CHEK TTOO STIM OCX MYNZ TRIB CNTG TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
LMDXF:USA
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
Website
https://www.lumiradx.com
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.